Dashboard
Manage Tickers

OLMAOlema Pharmaceuticals, Inc.

Nasdaq olema.com


$ 9.81 $ 0.18 (1.86 %)    

Friday, 17-May-2024 15:59:55 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 451.63 $ -0.22 (-0.05 %)
DIA $ 399.76 $ 0.74 (0.19 %)
SPY $ 529.24 $ 0.76 (0.14 %)
TLT $ 91.40 $ -0.62 (-0.67 %)
GLD $ 223.63 $ 3.63 (1.65 %)
$ 9.84
$ 9.93
$ 0.00 x 0
$ 0.00 x 0
$ 9.68 - $ 10.01
$ 5.02 - $ 17.79
547,955
na
546.85M
$ 2.07
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-08-2024 03-31-2024 10-Q
2 03-11-2024 12-31-2023 10-K
3 11-07-2023 09-30-2023 10-Q
4 08-08-2023 06-30-2023 10-Q
5 05-09-2023 03-31-2023 10-Q
6 03-09-2023 12-31-2022 10-K
7 11-08-2022 09-30-2022 10-Q
8 08-09-2022 06-30-2022 10-Q
9 05-09-2022 03-31-2022 10-Q
10 02-28-2022 12-31-2021 10-K
11 11-10-2021 09-30-2021 10-Q
12 08-10-2021 06-30-2021 10-Q
13 05-11-2021 03-31-2021 10-Q
14 03-17-2021 12-31-2020 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

hc-wainwright--co-reiterates-buy-on-olema-pharmaceuticals-maintains-30-price-target
HC Wainwright & Co. Reiterates Buy on Olem...
05/15/2024 17:58:39

HC Wainwright & Co. analyst Emily Bodnar reiterates Olema Pharmaceuticals (NASDAQ:OLMA) with a Buy and maintains $30 pri...

olema-oncology-announces-interim-results-from-phase-1b2-palazestrant-study-says-85-clinical-benefit-rate-observed-to-date-across-all-cbr-eligible-patients
Olema Oncology Announces Interim Results F...
05/15/2024 11:12:13

hc-wainwright--co-maintains-buy-on-olema-pharmaceuticals-raises-price-target-to-28
HC Wainwright & Co. Maintains Buy on Olema...
05/09/2024 19:31:28

HC Wainwright & Co. analyst Emily Bodnar maintains Olema Pharmaceuticals (NASDAQ:OLMA) with a Buy and raises the price t...

olema-pharmaceuticals-q1-eps-056-misses-051-estimate
Olema Pharmaceuticals Q1 EPS $(0.56) Misse...
05/08/2024 21:05:59

Olema Pharmaceuticals (NASDAQ:OLMA) reported quarterly losses of $(0.56) per share which missed the analyst consensus estimate ...

olema-pharmaceuticals-announced-that-it-will-present-new-clinical-data-from-the-companys-ongoing-phase-1b2-clinical-study-of-palazestrant-in-combination-with-cdk46-inhibitor-ribociclib-in-berlin-germany
Olema Pharmaceuticals Announced That It Wi...
05/08/2024 11:23:40

olema-pharmaceuticals-option-alert-oct-18-15-calls-at-the-ask-156--19-vs-1547-oi-earnings-514-after-close-est-ref1078
Olema Pharmaceuticals Option Alert: Oct 18...
05/03/2024 17:19:19

goldman-sachs-initiates-coverage-on-olema-pharmaceuticals-with-buy-rating-announces-price-target-of-24
Goldman Sachs Initiates Coverage On Olema ...
04/02/2024 11:09:16

Goldman Sachs analyst Richard Law initiates coverage on Olema Pharmaceuticals (NASDAQ:OLMA) with a Buy rating and announces ...

oppenheimer-reiterates-outperform-on-olema-pharmaceuticals-maintains-21-price-target
Oppenheimer Reiterates Outperform on Olema...
03/12/2024 12:18:02

Oppenheimer analyst Matthew Biegler reiterates Olema Pharmaceuticals (NASDAQ:OLMA) with a Outperform and maintains $21 price...

hc-wainwright--co-maintains-buy-on-olema-pharmaceuticals-lowers-price-target-to-25
HC Wainwright & Co. Maintains Buy on Olema...
03/12/2024 10:39:57

HC Wainwright & Co. analyst Emily Bodnar maintains Olema Pharmaceuticals (NASDAQ:OLMA) with a Buy and lowers the price t...

olema-pharmaceuticals-q4-eps-049-misses-048-estimate
Olema Pharmaceuticals Q4 EPS $(0.49) Misse...
03/11/2024 20:04:08

Olema Pharmaceuticals (NASDAQ:OLMA) reported quarterly losses of $(0.49) per share which missed the analyst consensus estimate ...

eaton-posts-strong-results-joins-ferrari-boot-barn-and-other-big-stocks-moving-higher-on-thursday
Eaton Posts Strong Results, Joins Ferrari,...
02/01/2024 15:46:02

U.S. stocks traded higher, with the Dow Jones gaining over 100 points on Thursday.

olema-pharmaceuticals-filed-prospectus-related-to-resale-of-up-to-132m-shares-of-common-stock-held-by-selling-stockholders
Olema Pharmaceuticals Filed Prospectus Rel...
01/31/2024 21:24:06

-S-3

citigroup-initiates-coverage-on-olema-pharmaceuticals-with-buy-rating-announces-price-target-of-20
Citigroup Initiates Coverage On Olema Phar...
01/30/2024 12:33:52

Citigroup analyst Yigal Nochomovitz initiates coverage on Olema Pharmaceuticals (NASDAQ:OLMA) with a Buy rating and announce...

olema-oncology-nominates-op-3136-as-a-development-candidate
Olema Oncology Nominates OP-3136 As A Deve...
01/08/2024 13:14:43

69m-bet-on-this-healthcare-stock-check-out-these-4-stocks-insiders-are-buying
$6.9M Bet On This Healthcare Stock? Check ...
12/19/2023 11:59:41

Although U.S. stocks closed mostly higher on Monday, there were a few notable insider trades.

insiders-buying-walt-disney-and-3-other-stocks
Insiders Buying Walt Disney And 3 Other St...
12/11/2023 12:17:16

Although U.S. stocks closed higher on Friday, there were a few notable insider trades.

olema-oncology-announces-palazestrant-demonstrates-attractive-combinability-with-cdk46-inhibitors-ribociclib-and-palbociclib-in-phase-1b2-studies
Olema Oncology Announces Palazestrant Demo...
12/05/2023 17:36:57

Palazestrant (OP-1250) in combination with the CDK 4/6 inhibitors, ribociclib and palbociclib, demonstrated no significant drug...

olema-oncology-to-present-new-palazestrant-clinical-data-in-combination-with-cdk46-inhibitors-at-2023-san-antonio-breast-cancer-symposium
Olema Oncology To Present New Palazestrant...
11/28/2023 22:11:08

12-health-care-stocks-moving-in-mondays-pre-market-session
12 Health Care Stocks Moving In Monday's P...
11/27/2023 13:06:58

olema-pharmaceuticals-q3-eps-048-beats-051-estimate
Olema Pharmaceuticals Q3 EPS $(0.48) Beats...
11/07/2023 22:08:09

Olema Pharmaceuticals (NASDAQ:OLMA) reported quarterly losses of $(0.48) per share which beat the analyst consensus estimate of...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION